金斯瑞生物科技(01548.HK)擬分拆傳奇生物並在納斯達克全球市場單獨上市
格隆匯5月14日丨金斯瑞生物科技(01548.HK)發佈公告,公司此前宣佈,傳奇生物以保密方式向美國證券交易委員會提交了一份與建議發售有關的註冊聲明草案。公司此前進一步宣佈了其股東和潛在投資者對建議分拆的若干疑問及其迴應。2020年5月13日(紐約時間),傳奇生物根據《美國證券法》向美國證券交易委員會提交了與建議發售有關的註冊聲明的公開文件。
建議發售的細節,包括規模和價格區間,尚未最終確定。於該公告日期,公司直接持有傳奇生物全部已發行股本的約76.9%。由於建議發售,公司在傳奇生物中的權益將減少,但是,在建議發售完成後,公司預計將仍繼續為傳奇生物的大股東。
如公司此前所宣佈,如建議發售完成,董事會建議通過以傳奇生物的美國存託憑證的實物分派方式,向合格的股東提供傳奇生物的美國存託憑證的保證配額,以適當考慮公司股東的利益。有關保證配額的細節尚未最終確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.